The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

This article belongs to the Special Issue Editorial Board Members’ Collection Series: Chronic Kidney Disease in Diabetes

Detalhes bibliográficos
Autores:	Sánchez-Briales, Paula, Marqués Vidas, María, López Sánchez, Paula, López Illazquez, María Victoria, Martín-Testillano, Lucía, Vedat-Ali, Aylin, Portolés Pérez, José María
Formato:	artículo
Fecha de publicación:	0024
País:	España
Recursos:	Universidad Autónoma de Madrid
Repositorio:	Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:	inglés
OAI Identifier:	oai:dnet:biblosearchi::a1186eeddf659fae0a945979b8a0e99d
Acesso em linha:	https://hdl.handle.net/10486/761201 https://dx.doi.org/10.3390/jcm13051360
Access Level:	acceso abierto
Palavra-chave:	chronic kidney disease fractional excretion SGLT2 inhibitors type 2 diabetes mellitus uric acid Medicina

Descrição
Resumo:	This article belongs to the Special Issue Editorial Board Members’ Collection Series: Chronic Kidney Disease in Diabetes